Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rathin Chakrabarty"'
Autor:
Minakshi Mazumdar, Debadatta Nayak, Rajkumar Manchanda, Pushpak Bhattacharjee, Rathin Chakrabarty, Shilpi Saha, Anil Khurana, Tanya Das, Samik Chakraborty, Shravanti Mukherjee, Gaurisankar Sa
Publikováno v:
Oncology Reports. 31:1589-1598
The adverse side-effects associated with chemotherapy during cancer treatment have shifted considerable focus towards therapies that are targeted but devoid of toxic side-effects. In the present study, the antitumorigenic activity of thuja, the bioac
Autor:
Debadatta Nayak, Shrutarshi Paul, Shravanti Mukherjee, Anil Khurana, Kirti Kajal, Sreeparna Chakraborty, Rajkumar Manchanda, Poulami Khan, Gaurisankar Sa, Deblina Guha, Rathin Chakrabarty, Pushpak Bhattacharjee, Shilpi Saha, Tanya Das
Publikováno v:
International journal of oncology. 47(2)
Adverse side effects of chemotherapy during cancer treatment have shifted considerable focus towards therapies that are not only targeted but are also devoid of toxic side effects. We evaluated the antitumorigenic activity of sulphur, and delineated
Autor:
Sreeparna Chakraborty, Poulami Khan, Debadatta Nayak, Rajkumar Manchanda, Deblina Guha, Anil Khurana, Shilpi Saha, Shravanti Mukherjee, Gaurisankar Sa, Rathin Chakrabarty, Kirti Kajal, Bhattacharjee Pushpak, Tanya Das, Shrutarshi Paul
Publikováno v:
Indian Journal of Research in Homoeopathy, Vol 9, Iss 4, Pp 288-300 (2015)
Adverse side effects of chemotherapy during cancer treatment have shifted considerable focus towards therapies that are not only targeted but are also devoid of toxic side effects. We evaluated the antitumorigenic activity of sulphur, and delineated
Autor:
Minakshi Mazumdar, Chinta Raveendar, Rathin Chakrabarty, Shravanti Mukherjee, Dewan Md Sakib Hossain, Uttam K. Ghosh, Gaurisankar Sa, Anil Khurana, Tanya Das, Sanhita Mukherjee, Chaturbhuj Nayek, Suchismita Mohanty, Shilpi Saha
Publikováno v:
BMC Complementary and Alternative Medicine
Background Complementary medicines, including homeopathy, are used by many patients with cancer, usually alongside with conventional treatment. However, the molecular mechanisms underneath the anti-cancer effect, if any, of these medicines have still